Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2022

Pharma News, 2022

ALS: Early disease mechanisms discovered
ALS: Early disease mechanisms discovered

Currently, there is no cure for amyotrophic lateral sclerosis (ALS). 

Polpharma in pole position for biosimilar Tysabri in Europe
Polpharma in pole position for biosimilar Tysabri in Europe
Polpharma Biologics has become the first company to file for approval in the EU of a biosimilar version of Biogen’s blockbuster multiple sclerosis therapy Tysabri. ...
High-flying experiment: Do stem cells grow better in space?
High-flying experiment: Do stem cells grow better in space?
Scientists at Cedars-Sinai Medical Center in Los Angeles are trying to find new ways to produce huge batches of a type of stem cell that can generate nearly any other type of cell in the body -- an...
EMA Accepts Byondis’ Application of Trastuzumab Duocarmazine for HER2-Positive Breast Cancer
EMA Accepts Byondis’ Application of Trastuzumab Duocarmazine for HER2-Positive Breast Cancer
The European Medicines Agency has accepted Byondis’ application for its investigational drug trastuzumab duocarmazine for treatment of patients with human epidermal growth factor receptor 2 (HER2...
Grünenthal Acquires Rights to Nebido From Bayer for Up to $503 Million
Grünenthal Acquires Rights to Nebido From Bayer for Up to $503 Million
Bayer has sold off the rights to Nebido (testosterone undecanoate), its injectable treatment for testosterone deficiency, to Grünenthal for approximately $503 million. ...
Microparticles could be used to deliver “self-boosting” vaccines
Microparticles could be used to deliver “self-boosting” vaccines

Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated.

FDA grants breakthrough status for Accucinch ventricular restoration system
FDA grants breakthrough status for Accucinch ventricular restoration system
Ancora Heart has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the Accucinch ventricular restoration system. ...
FDA Fast Tracks Investigational Drug for the Treatment of Recurrent Brain Cancer
FDA Fast Tracks Investigational Drug for the Treatment of Recurrent Brain Cancer
The Food and Drug Administration (FDA) recently granted Alpheus Medical orphan drug and fast track designations for its investigational CV-01 delivery of sonodynamic therapy as a potential treatme...
Alzheimer's Research Moves Ahead with Whole Blood Exchange, Tau Revelations
Alzheimer's Research Moves Ahead with Whole Blood Exchange, Tau Revelations

Many Alzheimer’s clinical trials researchers express optimism that they are entering a new era. 

Real-World Data Support the Use of Sobi and Sanofi’s Elocta for Hemophilia A
Real-World Data Support the Use of Sobi and Sanofi’s Elocta for Hemophilia A

Sobi and Sanofi’s Elocta (efmoroctocog alfa) has shown efficacy in a real-world study in patients with the rare genetic bleeding disorder hemophilia A.

Bavarian Nordic’s Danish Manufacturing Plant FDA-Inspected for Jynneos Monkeypox Vaccines
Bavarian Nordic’s Danish Manufacturing Plant FDA-Inspected for Jynneos Monkeypox Vaccines
The FDA has inspected a Bavarian Nordic manufacturing facility in Denmark which manufactures a monkeypox vaccine that’s now awaiting the agency’s green light to ship to the United States. ...
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today launched two human monkeypo...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand